pharmaceutical investing Verona Pharma plc Operational Update and Financial Results for the First Quarter Ended March 31, 2018
medical device investing AIT Therapeutics Receives Patent Allowance for Delivery of Inhaled Nitric Oxide at Concentrations of at Least 160ppm for Treatment of Bronchiolitis in Infants
pharmaceutical investing Verona Pharma Reports Positive Top-Line Data from Phase 2b Clinical Trial of RPL554
Anteros Returns High-Grade Lead-Zinc-Silver in Surface Samples from the MMZ at its Havens Steady VMS Property, Newfoundland
Walker Lane Resources Ltd. Receives Positive Results from Airborne Geophysical Surveys and Geological Mapping Completed by Coeur on the Silverknife Property, BC and also are Clarifying Details Related to their recent Nevada Transactions
